Bristol Myers Squibb Company $BMY Shares Sold by AIA Group Ltd
Alpha Vantage · MarketBeat · · AI-summarised by FinFlash
AIA Group Ltd significantly reduced its stake in Bristol Myers Squibb by 20.6% in the third quarter, selling over 30,000 shares. Despite this, other institutional investors increased their positions in the biopharmaceutical company, which recently reported strong quarterly earnings of Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.Understand the context